On the public citation graph

A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation

https://doi.org/10.1016/j.bbmt.2018.09.038
0 signed · 280 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1007/s00428-015-1803-yopenalex-snapshot
Consensus diagnostic histopathological criteria for acute gastrointestinal graft versus host disease improve interobserver reproducibility
inferredcites →https://doi.org/10.1007/s11357-013-9603-2openalex-snapshot
Aging of the mammalian gastrointestinal tract: a complex organ system
inferredcites →https://doi.org/10.1016/j.antiviral.2009.01.005openalex-snapshot
Alkoxyalkyl prodrugs of acyclic nucleoside phosphonates enhance oral antiviral activity and reduce toxicity: Current state of the art
inferredcites →https://doi.org/10.1016/j.antiviral.2014.10.005openalex-snapshot
Cidofovir and brincidofovir reduce the pathology caused by systemic infection with human type 5 adenovirus in immunosuppressed Syrian hamsters, while ribavirin is largely ineffective in this model
inferredcites →https://doi.org/10.1016/j.antiviral.2015.02.007openalex-snapshot
The efficacy and pharmacokinetics of brincidofovir for the treatment of lethal rabbitpox virus infection: A model of smallpox disease
inferredcites →https://doi.org/10.1016/j.antiviral.2017.01.009openalex-snapshot
Short-term clinical safety profile of brincidofovir: A favorable benefit–risk proposition in the treatment of smallpox
inferredcites →https://doi.org/10.1016/j.antiviral.2017.04.002openalex-snapshot
Efficacy of delayed brincidofovir treatment against a lethal rabbitpox virus challenge in New Zealand White rabbits
inferredcites →https://doi.org/10.1016/j.bbmt.2011.09.007openalex-snapshot
Safety and Efficacy of CMX001 as Salvage Therapy for Severe Adenovirus Infections in Immunocompromised Patients
inferredcites →https://doi.org/10.1016/j.bbmt.2011.12.286openalex-snapshot
Cmx001 as Therapy for Severe Adenovirus Infections in Immunocompromised Pediatric Patients: Single Experience in 5 Patients
inferredcites →https://doi.org/10.1016/j.bbmt.2012.05.015openalex-snapshot
Efficacy of a Viral Load-Based, Risk-Adapted, Preemptive Treatment Strategy for Prevention of Cytomegalovirus Disease after Hematopoietic Cell Transplantation
inferredcites →https://doi.org/10.1016/j.bbmt.2016.12.621openalex-snapshot
Brincidofovir for Asymptomatic Adenovirus Viremia in Pediatric and Adult Allogeneic Hematopoietic Cell Transplant Recipients: A Randomized Placebo-Controlled Phase II Trial
inferredcites →https://doi.org/10.1016/j.coviro.2011.10.011openalex-snapshot
Maribavir and human cytomegalovirus—what happened in the clinical trials and why might the drug have failed?
inferredcites →https://doi.org/10.1016/j.hoc.2010.11.011openalex-snapshot
Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients
inferredcites →https://doi.org/10.1016/j.idc.2010.01.008openalex-snapshot
Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients
inferredcites →https://doi.org/10.1016/j.jcv.2017.09.013openalex-snapshot
Disseminated adenovirus infection after allogeneic stem cell transplant and the potential role of brincidofovir – Case series and 10 year experience of management in an adult transplant cohort
inferredcites →https://doi.org/10.1016/s0166-3542(03)00110-4openalex-snapshot
Esterification of cidofovir with alkoxyalkanols increases oral bioavailability and diminishes drug accumulation in kidney
inferredcites →https://doi.org/10.1016/s1083-8791(03)00287-8openalex-snapshot
Cytomegalovirus in hematopoietic stem cell transplant recipients: current status, known challenges, and future strategies
inferredcites →https://doi.org/10.1016/s1473-3099(11)70024-xopenalex-snapshot
Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial
inferredcites →https://doi.org/10.1016/s2352-3026(15)00289-6openalex-snapshot
Cytomegalovirus viral load and mortality after haemopoietic stem cell transplantation in the era of pre-emptive therapy: a retrospective cohort study
inferredcites →https://doi.org/10.1021/jm300212sopenalex-snapshot
Classification of Inhibitors of Hepatic Organic Anion Transporting Polypeptides (OATPs): Influence of Protein Expression on Drug–Drug Interactions
inferredcites →https://doi.org/10.1038/modpathol.2009.44openalex-snapshot
Spectrum of histologic changes in colonic biopsies in patients treated with mycophenolate mofetil
inferredcites →https://doi.org/10.1046/j.1365-2141.2001.02519.xopenalex-snapshot
Cytomegalovirus seropositivity adversely influences outcome after T‐depleted unrelated donor transplant in patients with chronic myeloid leukaemia: the case for tailored graft‐versus‐host disease prophylaxis
inferredcites →https://doi.org/10.1056/nejmoa1303688openalex-snapshot
CMX001 to Prevent Cytomegalovirus Disease in Hematopoietic-Cell Transplantation
inferredcites →https://doi.org/10.1056/nejmoa1706640openalex-snapshot
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
inferredcites →https://doi.org/10.1086/339329openalex-snapshot
Definitions of Cytomegalovirus Infection and Disease in Transplant Recipients
inferredcites →https://doi.org/10.1086/421912openalex-snapshot
Oral Activity of Ether Lipid Ester Prodrugs of Cidofovir against Experimental Human Cytomegalovirus Infection
inferredcites →https://doi.org/10.1086/426831openalex-snapshot
Ether Lipid‐Ester Prodrugs of Acyclic Nucleoside Phosphonates: Activity against Adenovirus Replication In Vitro
inferredcites →https://doi.org/10.1086/656717openalex-snapshot
Efficacy of CMX001 against Herpes Simplex Virus Infections in Mice and Correlations with Drug Distribution Studies
inferredcites →https://doi.org/10.1093/cid/ciu364openalex-snapshot
Donor Cytomegalovirus Status Influences the Outcome of Allogeneic Stem Cell Transplant: A Study by the European Group for Blood and Marrow Transplantation
inferredcites →https://doi.org/10.1093/cid/cix804openalex-snapshot
Kinetics of Double-Stranded DNA Viremia After Allogeneic Hematopoietic Cell Transplantation
inferredcites →https://doi.org/10.1093/ofid/ofx163.725openalex-snapshot
Pharmacokinetics (PK) and Safety of Intravenous (IV) Brincidofovir (BCV) in Healthy Adult Subjects
inferredcites →https://doi.org/10.1097/00000478-197908000-00001openalex-snapshot
Gastrointestinal graft-versus-host disease in man
inferredcites →https://doi.org/10.1097/ftd.0000000000000353openalex-snapshot
Brincidofovir Is Not a Substrate for the Human Organic Anion Transporter 1: A Mechanistic Explanation for the Lack of Nephrotoxicity Observed in Clinical Studies
inferredcites →https://doi.org/10.1097/mph.0000000000001227openalex-snapshot
Brincidofovir (CMX001) Toxicity Associated With Epithelial Apoptosis and Crypt Drop Out in a Hematopoietic Cell Transplant Patient: Challenges in Distinguishing Drug Toxicity From GVHD
inferredcites →https://doi.org/10.1111/j.1432-2277.2005.00218.xopenalex-snapshot
The prevention of infection post-transplant: the role of prophylaxis, preemptive and empiric therapy
inferredcites →https://doi.org/10.1111/j.1600-6143.2008.02269.xopenalex-snapshot
Cidofovir Inhibits Polyomavirus BK Replication in Human Renal Tubular Cells Downstream of Viral Early Gene Expression
inferredcites →https://doi.org/10.1111/tid.12447openalex-snapshot
It's not too late: a proposal to standardize the terminology of “late‐onset” cytomegalovirus infection and disease in solid organ transplant recipients
inferredcites →https://doi.org/10.1124/mol.63.3.678openalex-snapshot
Increased Antiviral Activity of 1-O-Hexadecyloxypropyl-[2-14C]cidofovir in MRC-5 Human Lung Fibroblasts Is Explained by Unique Cellular Uptake and Metabolism
inferredcites →https://doi.org/10.1124/pr.110.002857openalex-snapshot
Organic Anion Transporting Polypeptide 1B1: a Genetically Polymorphic Transporter of Major Importance for Hepatic Drug Uptake
inferredcites →https://doi.org/10.1128/aac.00046-11openalex-snapshot
CMX001 (1- O -Hexadecyloxypropyl-Cidofovir) Inhibits Polyomavirus JC Replication in Human Brain Progenitor-Derived Astrocytes
inferredcites →https://doi.org/10.1128/aac.00184-07openalex-snapshot
Effect of Oral Treatment with Hexadecyloxypropyl-[( S )-9-(3-Hydroxy-2- Phosphonylmethoxypropyl)Adenine] [( S )-HPMPA] or Octadecyloxyethyl-( S )-HPMPA on Cowpox or Vaccinia Virus Infections in Mice
inferredcites →https://doi.org/10.1128/aac.01241-07openalex-snapshot
Anti-BK Virus Activity of Nucleoside Analogs
inferredcites →https://doi.org/10.1128/aac.05983-11openalex-snapshot
First Pharmacokinetic and Safety Study in Humans of the Novel Lipid Antiviral Conjugate CMX001, a Broad-Spectrum Oral Drug Active against Double-Stranded DNA Viruses
inferredcites →https://doi.org/10.1128/aac.46.4.991-995.2002openalex-snapshot
Enhanced Inhibition of Orthopoxvirus Replication In Vitro by Alkoxyalkyl Esters of Cidofovir and Cyclic Cidofovir
inferredcites →https://doi.org/10.1128/aac.46.8.2381-2386.2002openalex-snapshot
Alkoxyalkyl Esters of Cidofovir and Cyclic Cidofovir Exhibit Multiple-Log Enhancement of Antiviral Activity against Cytomegalovirus and Herpesvirus Replication In Vitro
inferredcites →https://doi.org/10.1128/aac.48.12.4745-4753.2004openalex-snapshot
Oral Activity of a Methylenecyclopropane Analog, Cyclopropavir, in Animal Models for Cytomegalovirus Infections
inferredcites →https://doi.org/10.1128/aac.49.9.3724-3733.2005openalex-snapshot
Comparative Activities of Lipid Esters of Cidofovir and Cyclic Cidofovir against Replication of Herpesviruses In Vitro
inferredcites →https://doi.org/10.1128/aac.50.4.1564-1566.2006openalex-snapshot
Ether Lipid Ester Derivatives of Cidofovir Inhibit Polyomavirus BK Replication In Vitro
inferredcites →https://doi.org/10.1177/106689690301100406openalex-snapshot
Histologic Features of Mycophenolate Mofetil-Related Colitis: A Graft-Versus-Host Disease-Like Pattern
inferredcites →https://doi.org/10.1182/blood-2003-10-3616openalex-snapshot
The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy
inferredcites →https://doi.org/10.1182/blood-2006-01-0254openalex-snapshot
An acute graft-versus-host disease activity index to predict survival after hematopoietic cell transplantation with myeloablative conditioning regimens
inferredcites →https://doi.org/10.1182/blood-2007-01-069294openalex-snapshot
Sirolimus-based graft-versus-host disease prophylaxis protects against cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation: a cohort analysis
inferredcites →https://doi.org/10.1182/blood-2008-10-143560openalex-snapshot
How we treat cytomegalovirus in hematopoietic cell transplant recipients
inferredcites →https://doi.org/10.1182/blood-2015-10-612747openalex-snapshot
How I treat acute graft-versus-host disease of the gastrointestinal tract and the liver
inferredcites →https://doi.org/10.1182/blood-2015-11-679639openalex-snapshot
Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis
inferredcites →https://doi.org/10.1182/blood-2016-10-748426openalex-snapshot
The cumulative burden of double-stranded DNA virus detection after allogeneic HCT is associated with increased mortality
inferredcites →https://doi.org/10.1182/blood-2016-11-749721openalex-snapshot
Brincidofovir is highly efficacious in controlling adenoviremia in pediatric recipients of hematopoietic cell transplant
inferredcites →https://doi.org/10.1186/s41687-017-0022-5openalex-snapshot
The Japanese version of the National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE): psychometric validation and discordance between clinician and patient assessments of adverse events
inferredcites →https://doi.org/10.3390/v3010047openalex-snapshot
Efficacy of CMX001 as a Post Exposure Antiviral in New Zealand White Rabbits Infected with Rabbitpox Virus, a Model for Orthopoxvirus Infections of Humans
inferredcites →https://doi.org/10.3390/v3020063openalex-snapshot
Efficacy of CMX001 as a Prophylactic and Presymptomatic Antiviral Agent in New Zealand White Rabbits Infected with Rabbitpox Virus, a Model for Orthopoxvirus Infections of Humans
inferredcites →https://doi.org/10.7326/0003-4819-118-3-199302010-00003openalex-snapshot
Ganciclovir Prophylaxis To Prevent Cytomegalovirus Disease after Allogeneic Marrow Transplant
inferredcites →https://doi.org/10.7326/0003-4819-118-3-199302010-00004openalex-snapshot
Ganciclovir Prophylaxis of Cytomegalovirus Infection and Disease in Allogeneic Bone Marrow Transplant Recipients: Results of a Placebo-Controlled, Double-Blind Trial

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4656748openalex-extracted
inferred← citeshttps://doi.org/10.1002/9781683670438.mcm0109openalex-snapshot
Human Polyomaviruses
inferred← citeshttps://doi.org/10.1002/9781683674849.mcm0109openalex-snapshot
Human Polyomaviruses
inferred← citeshttps://doi.org/10.1002/9783527810697.ch11openalex-snapshot
Antiviral Therapy of Adenovirus Infections
inferred← citeshttps://doi.org/10.1002/9783527810697.ch6openalex-snapshot
Antiviral Strategies Against the Human Cytomegalo Virus
inferred← citeshttps://doi.org/10.1002/9783527845088.ch15openalex-snapshot
Discovery and Development of Brincidofovir
inferred← citeshttps://doi.org/10.1002/acg2.53openalex-snapshot
Advances in CMV infection prevention and treatment after allo‐ HSCT
inferred← citeshttps://doi.org/10.1002/ila2.70026openalex-snapshot
Current Progress in Targeting Human Cytomegalovirus Infection
inferred← citeshttps://doi.org/10.1002/jcph.1363openalex-snapshot
Treatment and Prevention of CMV Disease in Transplant Recipients: Current Knowledge and Future Perspectives
inferred← citeshttps://doi.org/10.1002/rmv.2220openalex-snapshot
Antivirals against human polyomaviruses: Leaving no stone unturned
inferred← citeshttps://doi.org/10.1002/rmv.70116openalex-snapshot
An Update on Mpox: Focussing on Current and Emerging Antiviral Strategies
inferred← citeshttps://doi.org/10.1007/978-3-030-01751-4_24-1openalex-snapshot
Cytomegalovirus in Solid Organ Transplant Recipients: Prevention, Diagnosis, and Treatment
inferred← citeshttps://doi.org/10.1007/978-3-030-01751-4_25-1openalex-snapshot
Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients: Prevention, Diagnosis, and Treatment
inferred← citeshttps://doi.org/10.1007/978-3-030-01751-4_32-1openalex-snapshot
Respiratory Viral Pathogens in Solid Organ and Hematopoietic Stem Cell Transplant Recipients
inferred← citeshttps://doi.org/10.1007/978-3-030-25869-6_24openalex-snapshot
Cytomegalovirus in Solid Organ Transplant Recipients: Prevention, Diagnosis, and Treatment
inferred← citeshttps://doi.org/10.1007/978-3-030-25869-6_25openalex-snapshot
Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients: Prevention, Diagnosis, and Treatment
inferred← citeshttps://doi.org/10.1007/978-3-030-25869-6_32openalex-snapshot
Respiratory Viral Pathogens in Solid Organ and Hematopoietic Stem Cell Transplant Recipients
inferred← citeshttps://doi.org/10.1007/978-3-030-55244-2_17openalex-snapshot
Allogeneic Haemopoietic Stem Cell Transplantation
inferred← citeshttps://doi.org/10.1007/978-3-031-57369-9_15openalex-snapshot
Cytomegalovirus Infections in Hematopoietic Cell Transplant and Solid Organ Transplant Recipients
inferred← citeshttps://doi.org/10.1007/978-3-031-57369-9_18openalex-snapshot
Antiviral Agents: Cidofovir and Brincidofovir
inferred← citeshttps://doi.org/10.1007/978-981-16-0267-2_1openalex-snapshot
Antiviral Drugs Against Herpesviruses
inferred← citeshttps://doi.org/10.1007/s00210-023-02769-yopenalex-snapshot
Potential use of cidofovir, brincidofovir, and tecovirimat drugs in fighting monkeypox infection: recent trends and advancements
inferred← citeshttps://doi.org/10.1007/s00277-020-04362-2openalex-snapshot
Letermovir prophylaxis is effective in preventing cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: single-center real-world data
inferred← citeshttps://doi.org/10.1007/s00277-021-04642-5openalex-snapshot
Epstein–Barr virus and cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation in patients with non–Hodgkin lymphoma: the prevalence and impacts on outcomes
inferred← citeshttps://doi.org/10.1007/s10096-025-05242-1openalex-snapshot
From neglected to notoriety: a review of Mpox clinical features, virology, epidemiology, treatment and prevention strategies
inferred← citeshttps://doi.org/10.1007/s11899-020-00557-6openalex-snapshot
Moving Past Ganciclovir and Foscarnet: Advances in CMV Therapy
inferred← citeshttps://doi.org/10.1007/s11908-019-0699-0openalex-snapshot
CMV Prevention and Treatment in Transplantation: What’s New in 2019
inferred← citeshttps://doi.org/10.1007/s12185-021-03218-3openalex-snapshot
Incidence of refractory cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation
inferred← citeshttps://doi.org/10.1007/s15010-020-01521-5openalex-snapshot
Recommendations for screening, monitoring, prevention, and prophylaxis of infections in adult and pediatric patients receiving CAR T-cell therapy: a position paper
inferred← citeshttps://doi.org/10.1007/s40121-021-00452-4openalex-snapshot
Cytomegalovirus Infection and the Implications of Drug-Resistant Mutations in Pediatric Allogeneic Hematopoietic Stem Cell Transplant Recipients: A Retrospective Study from a Tertiary Hospital in China
inferred← citeshttps://doi.org/10.1007/s40121-025-01159-6openalex-snapshot
Tackling CMV in Transplant Recipients: Past, Present, and Future
inferred← citeshttps://doi.org/10.1007/s40262-023-01267-xopenalex-snapshot
Clinical and Translational Pharmacology Considerations for Anti-infectives Approved Under the FDA Animal Rule
inferred← citeshttps://doi.org/10.1007/s40506-021-00253-wopenalex-snapshot
CMV Infection in Hematopoietic Stem Cell Transplantation: Prevention and Treatment Strategies
inferred← citeshttps://doi.org/10.1007/s40506-023-00266-7openalex-snapshot
Monkeypox Outbreak: an Overview of Potential Therapeutic Options
inferred← citeshttps://doi.org/10.1016/b978-0-323-64198-2.00026-9openalex-snapshot
Cytomegalovirus
inferred← citeshttps://doi.org/10.1016/b978-0-323-82763-8.00071-6openalex-snapshot
Opportunistic Infections in Hematopoietic Stem Cell Transplantation
inferred← citeshttps://doi.org/10.1016/b978-0-323-82763-8.00159-xopenalex-snapshot
Cytomegalovirus
inferred← citeshttps://doi.org/10.1016/b978-0-323-82763-8.00255-7openalex-snapshot
Antiviral Agents
inferred← citeshttps://doi.org/10.1016/bs.armc.2021.09.001openalex-snapshot
Broad spectrum antiviral nucleosides—Our best hope for the future
inferred← citeshttps://doi.org/10.1016/bs.enz.2021.07.003openalex-snapshot
DNA polymerases of herpesviruses and their inhibitors
inferred← citeshttps://doi.org/10.1016/bs.seda.2019.10.005openalex-snapshot
Antiviral drugs
inferred← citeshttps://doi.org/10.1016/j.antiviral.2019.01.011openalex-snapshot
Clinical development of letermovir and maribavir: Overview of human cytomegalovirus drug resistance
inferred← citeshttps://doi.org/10.1016/j.antiviral.2019.104639openalex-snapshot
Artemisone demonstrates synergistic antiviral activity in combination with approved and experimental drugs active against human cytomegalovirus
inferred← citeshttps://doi.org/10.1016/j.antiviral.2020.104732openalex-snapshot
The direct and indirect consequences of cytomegalovirus infection and potential benefits of vaccination
inferred← citeshttps://doi.org/10.1016/j.antiviral.2020.104867openalex-snapshot
Gamma secretase inhibition impairs HCMV replication by reduction of immediate early gene expression at the transcriptional level
inferred← citeshttps://doi.org/10.1016/j.antiviral.2020.104872openalex-snapshot
Effect of brincidofovir on adenovirus and A549 cells transcriptome profiles
inferred← citeshttps://doi.org/10.1016/j.antiviral.2021.105034openalex-snapshot
Emerging antiviral therapeutics for human adenovirus infection: Recent developments and novel strategies
inferred← citeshttps://doi.org/10.1016/j.antiviral.2021.105182openalex-snapshot
Benefit-risk assessment for brincidofovir for the treatment of smallpox: U.S. Food and Drug Administration's Evaluation
inferred← citeshttps://doi.org/10.1016/j.antiviral.2024.105799openalex-snapshot
Oral USC-093, a novel homoserinamide analogue of the tyrosinamide (S)-HPMPA prodrug USC-087 has decreased nephrotoxicity while maintaining antiviral efficacy against human adenovirus infection of Syrian hamsters
inferred← citeshttps://doi.org/10.1016/j.antiviral.2024.105995openalex-snapshot
Treatment efficacy of cidofovir and brincidofovir against clade II Monkeypox virus isolates
inferred← citeshttps://doi.org/10.1016/j.antiviral.2025.106152openalex-snapshot
Overview on the management of herpes simplex virus infections: Current therapies and future directions
inferred← citeshttps://doi.org/10.1016/j.bbmt.2020.10.001openalex-snapshot
Negative Impact of Cytomegalovirus Reactivation on Survival in Adult Patients with Aplastic Anemia after an Allogeneic Hematopoietic Stem Cell Transplantation: A Report from Transplantation-Related Complication and Adult Aplastic Anemia Working Groups of the Japan Society for Hematopoietic Cell…
inferred← citeshttps://doi.org/10.1016/j.bcp.2022.115322openalex-snapshot
Acyclovir resistance in herpes simplex viruses: Prevalence and therapeutic alternatives
inferred← citeshttps://doi.org/10.1016/j.biopha.2026.119738openalex-snapshot
Acid sphingomyelinase is an age-dependent host cell factor for adenovirus entry and a pharmacological target for synergistic combination therapy with brincidofovir
inferred← citeshttps://doi.org/10.1016/j.bmc.2023.117276openalex-snapshot
Inhibition of the hERG potassium ion channel by different non-nucleoside human cytomegalovirus polymerase antiviral inhibitor series and the exploration of variations on a pyrroloquinoline core to reduce cardiotoxicity potential
inferred← citeshttps://doi.org/10.1016/j.cmi.2019.09.003openalex-snapshot
Anti-herpesvirus prophylaxis, pre-emptive treatment or no treatment in adults undergoing allogeneic transplant for haematological disease: systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1016/j.cmi.2025.01.033openalex-snapshot
How we diagnose and manage refractory and resistant herpes simplex virus mucocutaneous infection after haematopoietic cell transplantation
inferred← citeshttps://doi.org/10.1016/j.crmicr.2026.100608openalex-snapshot
Antiviral potential of black tea and blueberry extracts against monkeypox virus by targeting orthopoxvirus surface proteins
inferred← citeshttps://doi.org/10.1016/j.eclinm.2021.100787openalex-snapshot
A randomised, placebo-controlled phase 3 study to evaluate the efficacy and safety of ASP0113, a DNA-based CMV vaccine, in seropositive allogeneic haematopoietic cell transplant recipients
inferred← citeshttps://doi.org/10.1016/j.idc.2021.11.004openalex-snapshot
Antiviral Therapeutics in Pediatric Transplant Recipients
inferred← citeshttps://doi.org/10.1016/j.ijantimicag.2025.107537openalex-snapshot
The importance of drug exposure in the development of cytomegalovirus resistance
inferred← citeshttps://doi.org/10.1016/j.jcv.2019.04.007openalex-snapshot
New vaccines and antiviral drugs for cytomegalovirus
inferred← citeshttps://doi.org/10.1016/j.jcv.2022.105106openalex-snapshot
Effective Letermovir Prophylaxis of CMV infection post allogeneic hematopoietic cell transplantation: Results from the French temporary authorization of use compassionate program
inferred← citeshttps://doi.org/10.1016/j.jtct.2021.05.001openalex-snapshot
American Society for Transplantation and Cellular Therapy Series: #3—Prevention of Cytomegalovirus Infection and Disease After Hematopoietic Cell Transplantation
inferred← citeshttps://doi.org/10.1016/j.nantod.2023.101971openalex-snapshot
Tailoring multivalent nanomedicines for monkeypox
inferred← citeshttps://doi.org/10.1016/j.omtn.2023.05.016openalex-snapshot
Lipid nanoparticle-encapsulated, chemically modified anti-adenoviral siRNAs inhibit hepatic adenovirus infection in immunosuppressed Syrian hamsters
inferred← citeshttps://doi.org/10.1016/j.onehlt.2025.101030openalex-snapshot
Mpox unveiled: Global epidemiology, treatment advances, and prevention strategies
inferred← citeshttps://doi.org/10.1016/j.pediatrneurol.2019.10.004openalex-snapshot
HHV-6-Associated Neurological Disease in Children: Epidemiologic, Clinical, Diagnostic, and Treatment Considerations
inferred← citeshttps://doi.org/10.1016/j.tmaid.2022.102386openalex-snapshot
New challenges in human monkeypox outside Africa: A review and case report from Italy
inferred← citeshttps://doi.org/10.1016/j.trim.2023.101936openalex-snapshot
Extended duration letermovir in allogeneic hematopoietic stem cell transplant
inferred← citeshttps://doi.org/10.1016/j.trre.2024.100875openalex-snapshot
Management of cytomegalovirus in adult solid organ transplant patients: GESITRA-IC-SEIMC, CIBERINFEC, and SET recommendations update
inferred← citeshttps://doi.org/10.1016/s1473-3099(19)30107-0openalex-snapshot
Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL 7)
inferred← citeshttps://doi.org/10.1021/acs.chemrev.6c00118openalex-snapshot
Insights into the Life Cycle and Therapeutic Agents for Monkeypox Virus Infection
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.5c00863openalex-snapshot
Lipid-Optimized Sulfone-Bridged Cidofovir Prodrugs as Potent Antivirals Against Orthopoxviruses
inferred← citeshttps://doi.org/10.1021/acs.molpharmaceut.2c00668openalex-snapshot
NPP-669, a Novel Broad-Spectrum Antiviral Therapeutic with Excellent Cellular Uptake, Antiviral Potency, Oral Bioavailability, Preclinical Efficacy, and a Promising Safety Margin
inferred← citeshttps://doi.org/10.1021/acsinfecdis.5c00171openalex-snapshot
LAVR-289, an Acyclo-Nucleoside Phosphonate, Has Broad-Spectrum Activity against Herpesviruses
inferred← citeshttps://doi.org/10.1038/s41409-020-01178-6openalex-snapshot
Scoring system for clinically significant CMV infection in seropositive recipients following allogenic hematopoietic cell transplant: an SFGM-TC study
inferred← citeshttps://doi.org/10.1038/s41409-022-01863-8openalex-snapshot
New trends in the management of cytomegalovirus infection after allogeneic hematopoietic cell transplantation: a survey of the Infectious Diseases Working Pary of EBMT
inferred← citeshttps://doi.org/10.1038/s41579-021-00582-zopenalex-snapshot
Pathogenesis of human cytomegalovirus in the immunocompromised host
inferred← citeshttps://doi.org/10.1038/s41698-024-00709-4openalex-snapshot
Clinical implications of cytomegalovirus in glioblastoma progression and therapy
inferred← citeshttps://doi.org/10.1051/medsci/2020063openalex-snapshot
Le complexe terminase, une cible de choix dans le traitement de l’infection à cytomégalovirus humain
inferred← citeshttps://doi.org/10.1056/nejmcpc1904045openalex-snapshot
Case 31-2019: A 45-Year-Old Woman with Headache and Somnolence
inferred← citeshttps://doi.org/10.1080/0886022x.2020.1800491openalex-snapshot
Early diagnosis and successful treatment of cytomegalovirus peritonitis in children with primary nephrotic syndrome: case series and literature review
inferred← citeshttps://doi.org/10.1080/13543784.2025.2579018openalex-snapshot
Investigational treatments for cytomegalovirus infection in phase I and II study
inferred← citeshttps://doi.org/10.1080/13696998.2020.1843321openalex-snapshot
Cost-effectiveness of letermovir as cytomegalovirus prophylaxis in adult recipients of allogeneic hematopoietic stem cell transplantation in Hong Kong
inferred← citeshttps://doi.org/10.1080/14656566.2017.1322063openalex-snapshot
Update in the treatment of non-influenza respiratory virus infection in solid organ transplant recipients
inferred← citeshttps://doi.org/10.1080/14656566.2024.2353627openalex-snapshot
Advances in pharmacotherapies for cytomegalovirus infection: what is the current state of play?
inferred← citeshttps://doi.org/10.1080/14712598.2021.1857720openalex-snapshot
Cell therapy for cytomegalovirus infection
inferred← citeshttps://doi.org/10.1080/14740338.2019.1662787openalex-snapshot
Safety considerations with current and emerging antiviral therapies for cytomegalovirus infection in transplantation
inferred← citeshttps://doi.org/10.1080/14787210.2025.2532029openalex-snapshot
Brincidofovir in the Era of Mpox
inferred← citeshttps://doi.org/10.1080/17474086.2019.1657399openalex-snapshot
An update on the treatment of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation
inferred← citeshttps://doi.org/10.1080/17474086.2025.2509876openalex-snapshot
Benefits of primary prophylaxis with letermovir in patients after allogeneic hematopoietic stem cell transplantation for hematologic malignancies
inferred← citeshttps://doi.org/10.1080/21678707.2020.1835639openalex-snapshot
Advances in drug therapies for cytomegalovirus in transplantation: a focus on maribavir and letermovir
inferred← citeshttps://doi.org/10.1080/23808993.2021.1964951openalex-snapshot
Individualized management of cytomegalovirus in solid organ transplant recipients
inferred← citeshttps://doi.org/10.1093/bib/bbab580openalex-snapshot
ADENet: a novel network-based inference method for prediction of drug adverse events
inferred← citeshttps://doi.org/10.1093/bmb/ldz031openalex-snapshot
Advances in the treatment of cytomegalovirus
inferred← citeshttps://doi.org/10.1093/cid/ciaa1713openalex-snapshot
Letermovir and Maribavir for the Treatment and Prevention of Cytomegalovirus Infection in Solid Organ and Stem Cell Transplant Recipients
inferred← citeshttps://doi.org/10.1093/cid/ciac622openalex-snapshot
Antivirals With Activity Against Mpox: A Clinically Oriented Review
inferred← citeshttps://doi.org/10.1093/cid/ciae535openalex-snapshot
Current and Future Strategies for the Prevention and Treatment of Cytomegalovirus Infections in Transplantation
inferred← citeshttps://doi.org/10.1093/infdis/jiab212openalex-snapshot
Cytomegalovirus Viral Load Kinetics Predict Cytomegalovirus End-Organ Disease and Mortality After Hematopoietic Cell Transplant
inferred← citeshttps://doi.org/10.1093/infdis/jiad386openalex-snapshot
Cytomegalovirus Viral Load Threshold to Guide Preemptive Therapy in Hematopoietic Cell Transplant Recipients: Correlation With Cytomegalovirus Disease
inferred← citeshttps://doi.org/10.1093/infdis/jiz454openalex-snapshot
Cytomegalovirus Infection in Solid Organ and Hematopoietic Cell Transplantation: State of the Evidence
inferred← citeshttps://doi.org/10.1093/infdis/jiz493openalex-snapshot
Advances in the Development of Therapeutics for Cytomegalovirus Infections
inferred← citeshttps://doi.org/10.1093/jpids/piab072openalex-snapshot
Efficacy of Brincidofovir in Pediatric Stem Cell Transplant Recipients With Adenovirus Infections
inferred← citeshttps://doi.org/10.1093/ndt/gfaa249openalex-snapshot
Cytomegalovirus after kidney transplantation in 2020: moving towards personalized prevention
inferred← citeshttps://doi.org/10.1093/ofid/ofac310openalex-snapshot
Monkeypox: A Contemporary Review for Healthcare Professionals
inferred← citeshttps://doi.org/10.1093/ofid/ofaf612openalex-snapshot
Cytomegalovirus Viral Load Continues to Predict Poor Outcomes in Adults and Children Despite Improved Hematopoietic Cell Transplantation Success
inferred← citeshttps://doi.org/10.1097/cco.0000000000000580openalex-snapshot
Adoptive cell therapies for posttransplant infections
inferred← citeshttps://doi.org/10.1097/coh.0000000000001015openalex-snapshot
Mpox therapeutics in the post-STOMP/PALM era
inferred← citeshttps://doi.org/10.1097/mnh.0000000000000547openalex-snapshot
New treatments for cytomegalovirus in transplant patients
inferred← citeshttps://doi.org/10.1097/mog.0000000000000696openalex-snapshot
Recent developments in antimicrobial therapy for gastrointestinal infections
inferred← citeshttps://doi.org/10.1097/mot.0000000000000666openalex-snapshot
Updates on antiviral drugs for cytomegalovirus prevention and treatment
inferred← citeshttps://doi.org/10.1097/mph.0000000000002467openalex-snapshot
Threshold of Quantitative Cytomegalovirus DNA PCR for Preemptive Treatment in Pediatric Hematopoietic Stem Cell Transplant Recipients
inferred← citeshttps://doi.org/10.1097/pas.0000000000002197openalex-snapshot
Histologic Manifestations of Gastrointestinal Adenovirus Infection After Stem Cell Transplant
inferred← citeshttps://doi.org/10.1097/qco.0000000000000558openalex-snapshot
Approach to infection and disease due to adenoviruses in solid organ transplantation
inferred← citeshttps://doi.org/10.1097/qco.0000000000000592openalex-snapshot
Human herpesvirus 6 in transplant recipients: an update on diagnostic and treatment strategies
inferred← citeshttps://doi.org/10.1097/qco.0000000000000607openalex-snapshot
Resistant or refractory cytomegalovirus infections after hematopoietic cell transplantation: diagnosis and management
inferred← citeshttps://doi.org/10.1097/qco.0000000000001245openalex-snapshot
Adenovirus infection after cellular therapy: diagnostic and therapeutic challenges
inferred← citeshttps://doi.org/10.1097/tp.0000000000003988openalex-snapshot
Adenovirus Infection and Transplantation
inferred← citeshttps://doi.org/10.1097/tp.0000000000004856openalex-snapshot
Efficacy, Safety, and Cost-effectiveness Analysis of Antiviral Agents for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation Recipients
inferred← citeshttps://doi.org/10.1101/2024.11.01.621456openalex-snapshot
Synthesis of USC-093 and comparison with its promoiety enantiomer USC-093D against adenovirus in vitro and in a Syrian hamster model
inferred← citeshttps://doi.org/10.1101/2025.02.20.639249openalex-snapshot
LAVR-289, a new acyclo-nucleoside phosphonate having broad-spectrum activity against herpesviruses
inferred← citeshttps://doi.org/10.1111/1462-2920.16174openalex-snapshot
Insights into the monkeypox virus: Making of another pandemic within the pandemic?
inferred← citeshttps://doi.org/10.1111/bph.70258openalex-snapshot
Synergistic antiviral activity against human adenovirus through combination of itraconazole and brincidofovir
inferred← citeshttps://doi.org/10.1111/ctr.13512openalex-snapshot
Cytomegalovirus in solid organ transplant recipients—Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice
inferred← citeshttps://doi.org/10.1111/ctr.13666openalex-snapshot
Assessment and prevention of cytomegalovirus infection in allogeneic hematopoietic stem cell transplant and in solid organ transplant: A multidisciplinary consensus conference by the Italian GITMO, SITO, and AMCLI societies
inferred← citeshttps://doi.org/10.1111/cts.12483openalex-snapshot
Intravenous Hydroxypropyl β‐Cyclodextrin Formulation of Letermovir: A Phase I, Randomized, Single‐Ascending, and Multiple‐Dose Trial
inferred← citeshttps://doi.org/10.1111/imj.14462openalex-snapshot
New advances in the management of cytomegalovirus in allogeneic haemopoietic stem cell transplantation
inferred← citeshttps://doi.org/10.1111/imj.16587openalex-snapshot
Emerging concepts of CMV in transplantation
inferred← citeshttps://doi.org/10.1111/petr.13886openalex-snapshot
Diarrhea in the pediatric solid organ transplantation recipient: A multidisciplinary approach to diagnosis and management
inferred← citeshttps://doi.org/10.1111/tid.13776openalex-snapshot
Cidofovir, a choice for salvage treatment of cytomegalovirus infection in patients with haploidentical hematopoietic stem cell transplantation
inferred← citeshttps://doi.org/10.1111/tid.13977openalex-snapshot
Cytomegalovirus in the transplant setting: Where are we now and what happens next? A report from the International CMV Symposium 2021
inferred← citeshttps://doi.org/10.1111/tid.13994openalex-snapshot
Effective CMV prophylaxis with high‐dose valaciclovir in allogeneic hematopoietic stem‐cell recipients at a high risk of CMV infection
inferred← citeshttps://doi.org/10.1111/tid.14171openalex-snapshot
CMV prevention strategies in allogeneic hematopoietic cell transplantation; the role of prophylaxis and pre‐emptive monitoring in the era of letermovir
inferred← citeshttps://doi.org/10.1111/tid.14173openalex-snapshot
Adenovirus infection in allogeneic hematopoietic cell transplantation
inferred← citeshttps://doi.org/10.1111/tid.14183openalex-snapshot
Slaying the “Troll of Transplantation”—new frontiers in cytomegalovirus management: A report from the CMV International Symposium 2023
inferred← citeshttps://doi.org/10.1111/tid.70006openalex-snapshot
Efficacy and Safety of Letermovir for Cytomegalovirus Prophylaxis in Pediatric Hematopoietic Stem Cell Transplantation Recipients: A Systematic Review, Meta‐Analysis, and Meta‐Regression
inferred← citeshttps://doi.org/10.1128/aac.00489-24openalex-snapshot
NPP-669, a prodrug of cidofovir, is highly efficacious against human adenovirus infection in the permissive Syrian hamster model
inferred← citeshttps://doi.org/10.1128/aac.01226-22openalex-snapshot
New Perspectives on Antimicrobial Agents: Tecovirimat for Treatment of Human Monkeypox Virus
inferred← citeshttps://doi.org/10.1128/aac.01627-20openalex-snapshot
Investigational Antiviral Therapy Models for the Prevention and Treatment of Congenital Cytomegalovirus Infection during Pregnancy
inferred← citeshttps://doi.org/10.1128/cmr.00043-19openalex-snapshot
Progress and Challenges in the Prevention, Diagnosis, and Management of Cytomegalovirus Infection in Transplantation
inferred← citeshttps://doi.org/10.1128/jvi.00046-21openalex-snapshot
MAGI-1 PDZ2 Domain Blockade Averts Adenovirus Infection via Enhanced Proteolysis of the Apical Coxsackievirus and Adenovirus Receptor
inferred← citeshttps://doi.org/10.1128/jvi.00127-21openalex-snapshot
Acitretin and Retinoic Acid Derivatives Inhibit BK Polyomavirus Replication in Primary Human Proximal Renal Tubular Epithelial and Urothelial Cells
inferred← citeshttps://doi.org/10.1172/jci170236openalex-snapshot
Preparing for the next viral threat with broad-spectrum antivirals
inferred← citeshttps://doi.org/10.1177/03000605261456028openalex-snapshot
Cytomegalovirus prophylaxis using low-dose and ultra-low-dose valganciclovir for patients who have undergone allogeneic hematopoietic stem cell transplantation: A retrospective study
inferred← citeshttps://doi.org/10.1177/10600280231151751openalex-snapshot
Brincidofovir: A Novel Agent for the Treatment of Smallpox
inferred← citeshttps://doi.org/10.1177/20499361211018027openalex-snapshot
Post-allogeneic hematopoietic stem cell transplantation viral reactivations and viremias: a focused review on human herpesvirus-6, BK virus and adenovirus
inferred← citeshttps://doi.org/10.1182/blood.2019000956openalex-snapshot
How I treat CMV reactivation after allogeneic hematopoietic stem cell transplantation
inferred← citeshttps://doi.org/10.1182/blood.2019003687openalex-snapshot
How I manage infection risk and prevention in patients with lymphoid cancer
inferred← citeshttps://doi.org/10.1182/blood.2019004315openalex-snapshot
Oral brincidofovir decreases the incidence of HHV-6B viremia after allogeneic HCT
inferred← citeshttps://doi.org/10.1182/blood.2020009362openalex-snapshot
Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysis
inferred← citeshttps://doi.org/10.1182/bloodadvances.2019000802openalex-snapshot
Presentation of BK polyomavirus–associated hemorrhagic cystitis after allogeneic hematopoietic cell transplantation
inferred← citeshttps://doi.org/10.1182/bloodadvances.2019001120openalex-snapshot
BK virus–specific T-cell immune reconstitution after allogeneic hematopoietic cell transplantation
inferred← citeshttps://doi.org/10.1182/bloodadvances.2022008667openalex-snapshot
The promising efficacy of a risk-based letermovir use strategy in CMV-positive allogeneic hematopoietic cell recipients
inferred← citeshttps://doi.org/10.1182/bloodadvances.2023012175openalex-snapshot
Late cytomegalovirus disease after hematopoietic cell transplantation: significance of novel transplantation techniques
inferred← citeshttps://doi.org/10.1182/hematology.2023000459openalex-snapshot
Approaches to optimize outcomes in transplant recipients
inferred← citeshttps://doi.org/10.1186/s12879-022-07900-7openalex-snapshot
Human monkeypox: a comparison of the characteristics of the new epidemic to the endemic disease
inferred← citeshttps://doi.org/10.1186/s12985-026-03303-1openalex-snapshot
Assessment of combined antiviral drug treatment against selected α-, β-, and γ-herpesviruses
inferred← citeshttps://doi.org/10.1186/s43556-024-00226-7openalex-snapshot
Human cytomegalovirus: pathogenesis, prevention, and treatment
inferred← citeshttps://doi.org/10.1371/journal.pone.0223258openalex-snapshot
Targeted in-vitro-stimulation reveals highly proliferative multi-virus-specific human central memory T cells as candidates for prophylactic T cell therapy
inferred← citeshttps://doi.org/10.1515/pac-2018-1105openalex-snapshot
From academic research to founding a company: the story of AiCuris
inferred← citeshttps://doi.org/10.18433/jpps33138openalex-snapshot
Monkeypox: Virology, Pathophysiology, Clinical Characteristics, Epidemiology, Vaccines, Diagnosis, and Treatments
inferred← citeshttps://doi.org/10.21037/apm-21-2301openalex-snapshot
Current research status of cytomegalovirus infection after hematopoietic stem cell transplantation: a bibliometric analysis
inferred← citeshttps://doi.org/10.21037/ccts-20-174openalex-snapshot
Chronic and long-term complications after lung transplant: a narrative review
inferred← citeshttps://doi.org/10.2147/opth.s207976openalex-snapshot
Management of Adenoviral Keratoconjunctivitis: Challenges and Solutions
inferred← citeshttps://doi.org/10.2174/0113894501281263231218070841openalex-snapshot
Breaking Barriers: Current Advances and Future Directions in Mpox Therapy
inferred← citeshttps://doi.org/10.2174/011573398x307840240703045530openalex-snapshot
Cytomegalovirus and Mortality Risk: Is there also a Role in Obstructive Lung Diseases?
inferred← citeshttps://doi.org/10.2174/0122113525258072230920074245openalex-snapshot
Monkey Pox: Virology, Epidemiology, Vaccines, and Therapeutic Approaches
inferred← citeshttps://doi.org/10.21926/obm.transplant.1903081openalex-snapshot
Viral Infections in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Literature Review
inferred← citeshttps://doi.org/10.21926/obm.transplant.2102145openalex-snapshot
Cytomegalovirus in Lung Transplant
inferred← citeshttps://doi.org/10.2217/fmb-2019-0288openalex-snapshot
Brincidofovir: Understanding its Unique Profile and Potential Role Against Adenovirus and Other Viral Infections
inferred← citeshttps://doi.org/10.2478/ahp-2020-0005openalex-snapshot
Prophylaxis vs preemptive therapy in prevention of CMV infection: new insight on prophylactic strategy after allogeneic hematopoietic cell transplantation
inferred← citeshttps://doi.org/10.2991/chi.d.190613.001openalex-snapshot
Allogeneic Stem Cell Transplantation with CD34+ Cell Selection
inferred← citeshttps://doi.org/10.3324/haematol.2019.223073openalex-snapshot
Guidelines from the 2017 European Conference on Infections in Leukaemia for management of HHV-6 infection in patients with hematologic malignancies and after hematopoietic stem cell transplantation
inferred← citeshttps://doi.org/10.3389/fchem.2020.616863openalex-snapshot
Overview of Biologically Active Nucleoside Phosphonates
inferred← citeshttps://doi.org/10.3389/fchem.2022.889737openalex-snapshot
Phosphonates and Phosphonate Prodrugs in Medicinal Chemistry: Past Successes and Future Prospects
inferred← citeshttps://doi.org/10.3389/fimmu.2022.971156openalex-snapshot
Diagnosis and treatment for the early stage of cytomegalovirus infection during hematopoietic stem cell transplantation
inferred← citeshttps://doi.org/10.3389/fmed.2022.988847openalex-snapshot
Natural killer cell infusion for cytomegalovirus infection in pediatric patients with Wiskott-Aldrich syndrome following cord blood transplantation: A case report and literature review
inferred← citeshttps://doi.org/10.3389/fmicb.2020.01511openalex-snapshot
Human Cytomegalovirus Primary Infection and Reactivation: Insights From Virion-Carried Molecules
inferred← citeshttps://doi.org/10.3389/fmicb.2023.1321116openalex-snapshot
Anti-CMV therapy, what next? A systematic review
inferred← citeshttps://doi.org/10.3389/fmicb.2025.1518275openalex-snapshot
Epidemiology, clinical outcomes, and treatment patterns of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation in China: a scoping review and meta-analysis
inferred← citeshttps://doi.org/10.3389/fonc.2021.740079openalex-snapshot
Letermovir Prophylaxis for Cytomegalovirus Infection in Allogeneic Stem Cell Transplantation: A Real-World Experience
inferred← citeshttps://doi.org/10.3389/fped.2023.1098434openalex-snapshot
Prevention and management of CMV infection in pediatric solid organ transplant recipients
inferred← citeshttps://doi.org/10.3389/fped.2023.1180392openalex-snapshot
Cytomegalovirus in children undergoing haematopoietic stem cell transplantation: a diagnostic and therapeutic approach to antiviral resistance
inferred← citeshttps://doi.org/10.3390/biomedicines11020278openalex-snapshot
Oral Brincidofovir Therapy for Monkeypox Outbreak: A Focused Review on the Therapeutic Potential, Clinical Studies, Patent Literature, and Prospects
inferred← citeshttps://doi.org/10.3390/ijms20071636openalex-snapshot
Cellular Cullin RING Ubiquitin Ligases: Druggable Host Dependency Factors of Cytomegaloviruses
inferred← citeshttps://doi.org/10.3390/ijms20112666openalex-snapshot
Cytomegalovirus Infections after Hematopoietic Stem Cell Transplantation: Current Status and Future Immunotherapy
inferred← citeshttps://doi.org/10.3390/ijms21041376openalex-snapshot
Potential Therapeutic Approaches Against Brain Diseases Associated with Cytomegalovirus Infections
inferred← citeshttps://doi.org/10.3390/ijms23073431openalex-snapshot
40 Years after the Registration of Acyclovir: Do We Need New Anti-Herpetic Drugs?
inferred← citeshttps://doi.org/10.3390/jcm11164827openalex-snapshot
Adenovirus Infection in Pediatric Hematopoietic Cell Transplantation: A Challenge Still Open for Survival
inferred← citeshttps://doi.org/10.3390/microorganisms9040684openalex-snapshot
Successful Use of Heterologous CMV-Reactive T Lymphocyte to Treat Severe Refractory Cytomegalovirus (CMV) Infection in a Liver Transplanted Patient: Correlation of the Host Antiviral Immune Reconstitution with CMV Viral Load and CMV miRNome
inferred← citeshttps://doi.org/10.3390/molecules24050997openalex-snapshot
Novel Therapeutics for Epstein–Barr Virus
inferred← citeshttps://doi.org/10.3390/molecules26041132openalex-snapshot
Advances and Perspectives in the Management of Varicella-Zoster Virus Infections
inferred← citeshttps://doi.org/10.3390/pharmaceutics15010163openalex-snapshot
Optimizing Antiviral Dosing for HSV and CMV Treatment in Immunocompromised Patients
inferred← citeshttps://doi.org/10.3390/tropicalmed7120439openalex-snapshot
Challenges, Recent Advances and Perspectives in the Treatment of Human Cytomegalovirus Infections
inferred← citeshttps://doi.org/10.3390/v13030474openalex-snapshot
Small Molecules—Prospective Novel HCMV Inhibitors
inferred← citeshttps://doi.org/10.3390/v13071228openalex-snapshot
Current Drugs to Treat Infections with Herpes Simplex Viruses-1 and -2
inferred← citeshttps://doi.org/10.3390/v13071353openalex-snapshot
Chk1 and the Host Cell DNA Damage Response as a Potential Antiviral Target in BK Polyomavirus Infection
inferred← citeshttps://doi.org/10.3390/v13102001openalex-snapshot
Cytomegalovirus Infections in Children with Primary and Secondary Immune Deficiencies
inferred← citeshttps://doi.org/10.3390/v14102155openalex-snapshot
Monkeypox: A Comprehensive Review
showing the first 200 of 218
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.